E. Weiller

13.4k total citations · 3 hit papers
40 papers, 10.8k citations indexed

About

E. Weiller is a scholar working on Psychiatry and Mental health, Clinical Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, E. Weiller has authored 40 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 13 papers in Clinical Psychology and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in E. Weiller's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Schizophrenia research and treatment (10 papers) and Psychosomatic Disorders and Their Treatments (7 papers). E. Weiller is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Schizophrenia research and treatment (10 papers) and Psychosomatic Disorders and Their Treatments (7 papers). E. Weiller collaborates with scholars based in France, United States and Denmark. E. Weiller's co-authors include Y. Lecrubier, David V. Sheehan, T. Hergueta, Kathy H. Sheehan, Patrícia Brandão Amorim, John A. Schinka, A Keskiner, J.C. Bisserbe, Pascal Boyer and W. Maier and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Affective Disorders and European Neuropsychopharmacology.

In The Last Decade

E. Weiller

39 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mini international neuropsychiatric interview

1998 5.2k citations Y. Lecrubier, David V. Sheehan et al. European Psychiatry profile →
The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI

1997 2.9k citations Y. Lecrubier, David V. Sheehan et al. European Psychiatry profile →
The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability

1997 1.7k citations David V. Sheehan, Y. Lecrubier et al. European Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Weiller France	17	4.9k	3.2k	3.0k	2.1k	1.6k	40	10.8k
Miriam Gibbon United States	14	7.7k 1.6×	4.3k 1.3×	3.3k 1.1×	2.7k 1.3×	1.6k 1.0×	15	13.6k
Patrícia Brandão Amorim Brazil	4	5.3k 1.1×	3.6k 1.1×	3.0k 1.0×	2.6k 1.3×	1.8k 1.1×	29	12.9k
Richard van Dyck Netherlands	68	7.6k 1.6×	4.7k 1.5×	4.9k 1.6×	2.2k 1.1×	2.2k 1.4×	218	15.8k
Vladeta Ajdacic‐Gross Switzerland	48	4.2k 0.9×	2.4k 0.7×	2.2k 0.7×	1.4k 0.7×	1.5k 0.9×	216	9.2k
Wai Tat Chiu United States	22	7.6k 1.6×	2.1k 0.7×	4.2k 1.4×	1.9k 0.9×	2.7k 1.7×	34	13.4k
Carolyn M. Mazure United States	49	4.2k 0.9×	1.9k 0.6×	1.5k 0.5×	1.5k 0.8×	1.3k 0.8×	188	11.1k
Naomi M. Simon United States	56	6.2k 1.3×	2.4k 0.7×	3.1k 1.0×	1.6k 0.8×	1.6k 1.0×	267	11.3k
Martin Hautzinger Germany	54	4.2k 0.9×	2.0k 0.6×	2.7k 0.9×	1.6k 0.8×	1.7k 1.1×	331	9.5k
Kay Wilhelm Australia	56	3.9k 0.8×	2.5k 0.8×	1.8k 0.6×	1.3k 0.6×	2.1k 1.3×	243	10.6k
Philippe Courtet France	56	6.8k 1.4×	3.8k 1.2×	2.2k 0.7×	1.3k 0.6×	1.9k 1.2×	409	12.0k

Countries citing papers authored by E. Weiller

Since Specialization

Citations

This map shows the geographic impact of E. Weiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Weiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Weiller more than expected).

Fields of papers citing papers by E. Weiller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Weiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Weiller. The network helps show where E. Weiller may publish in the future.

Co-authorship network of co-authors of E. Weiller

This figure shows the co-authorship network connecting the top 25 collaborators of E. Weiller. A scholar is included among the top collaborators of E. Weiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Weiller. E. Weiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marder, S.R., et al.. (2016). An interventional, multi-center, randomized, double-blind, placebo-controlled, active reference, flexible dose study of brexpiprazole in adults with acute schizophrenia. European Psychiatry. 33(S1). S99–S99. 8 indexed citations

Weiss, Catherine, et al.. (2016). Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies. European Psychiatry. 33(S1). S109–S109. 1 indexed citations

Weiller, E., et al.. (2015). P2.f.018 Effect of adjunctive brexpiprazole (OPC-34712) on depressive symptoms in patients with symptoms of anxious distress: results from post-hoc analyses. European Neuropsychopharmacology. 25. S444–S445. 2 indexed citations

Skuban, Aleksandar, et al.. (2015). P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies. European Neuropsychopharmacology. 25. S522–S523. 3 indexed citations

Fleischhacker, WW, Mary Hobart, John Ouyang, et al.. (2015). P.3.d.079 Brexpiprazole (OPC-34712) efficacy and safety as maintenance therapy in adults with schizophrenia: Randomised, double-blind, placebo-controlled study. European Neuropsychopharmacology. 25. S527–S527. 1 indexed citations

McIntyre, Roger S., Mauricio Tohen, Michael Berk, Jun Zhao, & E. Weiller. (2013). DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. Journal of Affective Disorders. 150(2). 378–383. 48 indexed citations

Azorin, J.-M., Christophe Sapin, & E. Weiller. (2012). Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses. Journal of Affective Disorders. 145(1). 62–69. 41 indexed citations

Boulenger, J.P., et al.. (2010). Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine. Current Medical Research and Opinion. 26(3). 605–614. 15 indexed citations

Lecrubier, Y., E. Weiller, Henning Andersen, & David S. Baldwin. (2006). Qualitative changes in symptomatology before and after treatment to remission in generalised anxiety disorder and major depression. ePrints Soton (University of Southampton). 2 indexed citations

10.

Lecrubier, Y. & E. Weiller. (1999). Características, reconocimiento y tratamiento de los distímicos en la asistencia primaria. 6(1). 49–54. 1 indexed citations

11.

Amorim, Patrícia Brandão, Y. Lecrubier, E. Weiller, T. Hergueta, & David V. Sheehan. (1998). DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. European Psychiatry. 13(1). 26–34. 267 indexed citations

12.

Weiller, E., J.C. Bisserbe, W. Maier, & Y. Lecrubier. (1998). Prevalence and recognition of anxiety syndromes in five European primary care settings. The British Journal of Psychiatry. 173(S34). 18–23. 109 indexed citations

13.

Sheehan, David V., Y. Lecrubier, Kathy H. Sheehan, et al.. (1998). La Validez de la Entrevista Neuropsiquiátrica Intemacional Reducida (MINI) según la SCID-P y su fiabilidad. 5(1). 25–35. 1 indexed citations

14.

Sheehan, David V., Y. Lecrubier, Kathy H. Sheehan, et al.. (1997). The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry. 12(5). 232–241. 1744 indexed citations breakdown →

15.

Weiller, E., J.C. Bisserbe, Pascal Boyer, J. P. Lépine, & Y. Lecrubier. (1996). Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder. The British Journal of Psychiatry. 168(2). 169–174. 180 indexed citations

16.

Lecrubier, Y., Pascal Boyer, J.P. Lépine, & E. Weiller. (1996). The identification of psychiatric disorders in primary care. European Psychiatry. 11. 178s–179s. 3 indexed citations

17.

Weiller, E., Pascal Boyer, Jean‐Pierre Lépine, & Y. Lecrubier. (1994). Prevalence of recurrent brief depression in primary care. European Archives of Psychiatry and Clinical Neuroscience. 244(4). 174–181. 25 indexed citations

18.

Weiller, E., Y. Lecrubier, W. Maier, & T. Bedirhan Üstün. (1994). The relevance of recurrent bried depression in primary care. European Archives of Psychiatry and Clinical Neuroscience. 244(4). 182–189. 24 indexed citations

19.

Bensimon, G., Dominique Benoît, Lucette Lacomblez, et al.. (1991). Antagonism by modafinil of the psychomotor and cognitive impairment induced by sleep-deprivation in 12 healthy volunteers. European Psychiatry. 6(2). 93–97. 23 indexed citations

20.

Danjou, P., D. Warot, E. Weiller, L. Lacomblez, & A Puech. (1991). [Personality of healthy volunteers. Normality and paradox].. PubMed. 46(2). 125–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact